Paola Nisticò

13PUBLICATIONS
85CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Artificial life and complex adaptive systemsMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 27, 2026
Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC.

Roberta Melchionna, Francesca Di Modugno, Anna Di Carlo

|May 11, 2025
Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.

Nicla Porciello, Filippo Gallina, Giuseppe Frisullo

|Jun 25, 2024
ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB.

Ornella Franzese, Belinda Palermo, Giuseppe Frisullo

|Feb 05, 2024
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer.

Alessandra Rigamonti, Marika Viatore, Rebecca Polidori

|Oct 29, 2023
CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response.

Belinda Palermo, Ornella Franzese, Giuseppe Frisullo

|Aug 23, 2023
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.

Paola Trono, Annalisa Tocci, Belinda Palermo

Pageof 3

Frequent Collaborators

3 joint publications

Lorenzo D'Ambrosio

3 joint publications

Belinda Palermo

2 joint publications

Iole Macchia

2 joint publications

Valentina La Sorsa